Undaria pinnatifida ameliorates nasal inflammation by inhibiting eosinophil and mast cell activation and modulating the NF‐κB/MAPKs signaling pathway
Immunity, Inflammation and Disease · 2024
DOI: 10.1002/iid3.1215 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2024. Verfasst von Zhen Nan Yu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, Jeonbuk National University Medical School, Jeonju, South Korea. Hauptthemen laut MEDLINE: Eosinophils, Rhinitis, Allergic, Edible Seaweeds, Undaria. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Food Research Institute.
Abstract (Originalsprache)
Background
Allergic rhinitis (AR) is the most prevalent form of atopic disease. Undaria pinnatifida has potent antioxidative, antidiabetic, and anti‐inflammatory properties.
Aims
We investigated the immunomodulatory effect of Undaria pinnatifida extract (UPE) on allergic inflammation in an AR mouse model. Materials & Methods Mice were sensitized and intranasally challenged with ovalbumin (OVA), and the Th1/Th2 and Th17/Treg‐related cytokines and histopathology were exanimated after UPE treatments. Enzyme‐linked immunosorbent assay was performed using serum samples and NALF to detect OVA‐specific immunoglobulins and inflammatory cytokines. Mitogen‐activated protein kinases (MAPKs) were measured by western blotting analysis, and an in vitro study measured mast cell activation induced by compound 48/80.
Results
After UPE treatment, nasal and lung allergy symptoms, nasal mucosal swelling, and goblet cell hyperplasia were ameliorated. Oral UPE regulated the balance of Th1/Th2 and Th17/Treg cell differentiation in AR mice in a dose‐dependent manner. In addition, UPE attenuated the migration of eosinophils and mast cells to the nasal mucosa by suppressing nuclear factor kappa B (NF‐κB)/MAPKs. The levels of anti‐OVA IgE and IgG 1 were also decreased.
Discussion
UPE inhibited inflammation by regulating the NF‐κB/MAPKs signaling pathway and supressing the activation of critical immune cells such as eosinophils and mast cells.
Conclusion
UPE may have therapeutic potential for AR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomy, Jeonbuk National University Medical School, Jeonju, South Korea.
- Department of Basic Medicine, School of Medicine, Liaocheng University, Liaocheng, Shandong, China.
- Department of Pulmonary and Critical Care Medicine, Yantai Yuhuangding Hospital, Yantai, China.
- Department of Food Science and Biotechnology, Gachon University, Seongnam, South Korea.
- Division of Food Functionality Research, Korea Food Research Institute, Wanju, South Korea.
- Division of Food Biotechnology Program, Korea University of Science and Technology, Daejeon, South Korea.
ORCID-Profile: Zhen Nan Yu
Förderung
- Korea Food Research Institute
Zitieren
APA
Yu, Z. N., Fan, Y. J., Nguyen, T. V., Piao, C. H., Lee, B. H., Lee, S. Y., Shin, H. S., Song, C. H., & Chai, O. H. (2024). Undaria pinnatifida ameliorates nasal inflammation by inhibiting eosinophil and mast cell activation and modulating the NF‐κB/MAPKs signaling pathway. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.1215
Vancouver
Yu ZN, Fan YJ, Nguyen TV, Piao CH, Lee BH, Lee SY, et al. Undaria pinnatifida ameliorates nasal inflammation by inhibiting eosinophil and mast cell activation and modulating the NF‐κB/MAPKs signaling pathway. Immunity, Inflammation and Disease. 2024. doi:10.1002/iid3.1215
BibTeX
@article{Yu2024,
author = {Yu, Zhen Nan and Fan, Yan Jing and Nguyen, Thi Van and Piao, Chun Hua and Lee, Byung-Hoo and Lee, So-Young and Shin, Hee Soon and Song, Chang Ho and Chai, Ok Hee},
title = {Undaria pinnatifida ameliorates nasal inflammation by inhibiting eosinophil and mast cell activation and modulating the NF‐κB/MAPKs signaling pathway},
journal = {Immunity, Inflammation and Disease},
year = {2024},
doi = {10.1002/iid3.1215}
}
EUVIMED